Comparative review of Francisella tularensis and Francisella novicida

Frontiers in Cellular and Infection Microbiology

Volumn 5, Issue MAR, 2014, Pages

  Kingry, Luke C ^a   Petersen, Jeannine M ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Francisella novicida; Francisella tularensis; Intracellular pathogen; Tularemia; Virulence

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; INFLAMMASOME; MICRORNA 155; O ANTIGEN; QUINOLONE DERIVATIVE; TETRACYCLINE; TOLL LIKE RECEPTOR; AMINOGLYCOSIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TETRACYCLINE DERIVATIVE; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; URIDINE DIPHOSPHATE GLUCOSE 4 EPIMERASE;

ANTIBIOTIC RESISTANCE; BACTERIAL VIRULENCE; COLONY FORMING UNIT; CRISPR CAS SYSTEM; CROSS RESISTANCE; DISEASE TRANSMISSION; DNA DNA HYBRIDIZATION; DNA MODIFICATION; DNA RESTRICTION; FRANCISELLA NOVICIDA; FRANCISELLA TULARENSIS; FUNCTIONAL GENOMICS; GENETIC RECOMBINATION; GENOME ANALYSIS; HUMAN; IMMUNE RESPONSE; LD 50; NONHUMAN; PHENOTYPIC VARIATION; REVIEW; TULAREMIA; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL TRANSMISSION; BACTERIUM IDENTIFICATION; DOWN REGULATION; GENE AMPLIFICATION; HOST PATHOGEN INTERACTION; INNATE IMMUNITY; PATHOGENESIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE;

EID: 84898739250     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2014.00035     Document Type: Review

References (147)

1. Abplanalp, A. L., Morris, I. R., Parida, B. K., Teale, J. M., and Berton, M. T. (2009). TLR-dependent control of Francisella tularensis infection and host inflammatory responses. PLoS ONE 4:e7920. doi: 10.1371/journal.pone.0007920
2. Achtman, M. (2008). Evolution, population structure, and phylogeography of genetically monomorphic bacterial pathogens. Annu. Rev. Microbiol. 62, 53-70. doi: 10.1146/annurev.micro.62.081307.162832
3. Anthony, L. S., Gu, M. Z., Cowley, S. C., Leung, W. W., and Nano, F. E. (1991). Transformation and allelic replacement in Francisella spp. J. Gen. Microbiol. 137, 2697-2703.
4. Antwerpen, M. H., Schacht, E., Kaysser, P., and Splettstoesser, W. D. (2013). Complete genome sequence of a Francisella tularensis subsp. holarctica strain from Germany causing lethal infection in common marmosets. Genome Announc. 1:e00135. doi: 10.1128/genomeA.00135-12
5. Bandara, A. B., Champion, A. E., Wang, X., Berg, G., Apicella, M. A., McLendon, M., et al. (2011). Isolation and mutagenesis of a capsule-like complex (CLC) from Francisella tularensis, and contribution of the CLC to F. tularensis virulence in mice. PLoS ONE 6:e19003. doi: 10.1371/journal.pone.0019003
6. Barabote, R. D., Xie, G., Brettin, T. S., Hinrichs, S. H., Fey, P. D., Jay, J. J., et al. (2009). Complete genome sequence of Francisella tularensis subspecies holarctica FTNF002-00. PLoS ONE 4:e7041. doi: 10.1371/journal.pone.0007041
7. Barker, J. H., Kaufman, J. W., Zhang, D. S., and Weiss, J. P. (2014). Metabolic labeling to characterize the overall composition of Francisella Lipid A and LPS grown in broth and in human phagocytes. Innate Immun. 20, 88-103. doi: 10.1177/1753425913485308
8. Barker, J. R., Chong, A., Wehrly, T. D., Yu, J. J., Rodriguez, S. A., Liu, J., et al. (2009). The Francisella tularensis pathogenicity island encodes a secretion system that is required for phagosome escape and virulence. Mol. Microbiol. 74, 1459-1470. doi: 10.1111/j.1365-2958.2009.06947.x
9. Barns, S. M., Grow, C. C., Okinaka, R. T., Keim, P., and Kuske, C. R. (2005). Detection of diverse new Francisella-like bacteria in environmental samples. Appl. Environ. Microbiol. 71, 5494-5500. doi: 10.1128/AEM.71.9.5494-5500.2005
10. Bauernfeind, F., and Hornung, V. (2013). Of inflammasomes and pathogens-sensing of microbes by the inflammasome. EMBO Mol. Med. 5, 814-826. doi: 10.1002/emmm.201201771
11. Beckstrom-Sternberg, S. M., Auerbach, R. K., Godbole, S., Pearson, J. V., Beckstrom-Sternberg, J. S., Deng, Z., et al. (2007). Complete genomic characterization of a pathogenic A.II strain of Francisella tularensis subspecies tularensis. PLoS ONE 2:e947. doi: 10.1371/journal.pone.0000947
12. Bell, J. F., Owen, C. R., and Larson, C. L. (1955). Virulence of Bacterium tularense. I. A study of the virulence of Bacterium tularense in mice, guinea pigs, and rabbits. J. Infect. Dis. 97, 162-166.
13. Ben Nasr, A., and Klimpel, G. R. (2008). Subversion of complement activation at the bacterial surface promotes serum resistance and opsonophagocytosis of Francisella tularensis. J. Leukoc. Biol. 84, 77-85. doi: 10.1189/jlb.0807526
14. Berrada, Z. L., and Telford, S. R. 3rd. (2010). Diversity of Francisella species in environmental samples from Martha's Vineyard, Massachusetts. Microb. Ecol. 59, 277-283. doi: 10.1007/s00248-009-9568-y
15. Birdsell, D. N., Stewart, T., Vogler, A. J., Lawaczeck, E., Diggs, A., Sylvester, T. L., et al. (2009). Francisella tularensis subsp. novicida isolated from a human in Arizona. BMC Res. Notes 2:223. doi: 10.1186/1756-0500-2-223
16. Brett, M., Doppalapudi, A., Respicio-Kingry, L. B., Myers, D., Husband, B., Pollard, K., et al. (2012). Francisella novicida bacteremia after a near-drowning accident. J. Clin. Microbiol. 50, 2826-2829. doi: 10.1128/JCM.00995-12
17. Bröms, J. E., Meyer, L., Sun, K., Lavander, M., and Sjöstedt, A. (2012). Unique substrates secreted by the type VI secretion system of Francisella tularensis during intramacrophage infection. PLoS ONE 7:e50473. doi: 10.1371/journal.pone.0050473
18. Bröms, J. E., Sjöstedt, A., and Lavander, M. (2010). The role of the Francisella tularensis pathogenicity island in Type VI secretion, intracellular survival, and modulation of host cell signaling. Front. Microbiol. 1:136. doi: 10.3389/fmicb.2010.00136
19. Butchar, J. P., Cremer, T. J., Clay, C. D., Gavrilin, M. A., Wewers, M. D., Marsh, C. B., et al. (2008). Microarray analysis of human monocytes infected with Francisella tularensis identifies new targets of host response subversion. PLoS ONE 3:e2924. doi: 10.1371/journal.pone.0002924
20. Carniel, E. A. I., Cornelis, G., Fukushima, H., Guinet, F., Isberg, R., Pham, J., et al. (2006). "Y. enterocolitica and Y. pseudotuberculosis," in The Prokaryotes: A Handbook on the Biology of Bacteria, 3rd Edn., eds M. Dworkin, S. Falkow, E. Rosenberg, K.-H. Schleifer, and E. Stackebrandt (New York, NY: Springer Verlag), 270-398.
21. Case, E. D., Chong, A., Wehrly, T. D., Hansen, B., Child, R., Hwang, S., et al. (2014). The Francisella O-antigen mediates survival in the macrophage cytosol via autophagy avoidance. Cell. Microbiol. doi: 10.1111/cmi.12246. [Epub ahead of print].
22. Celebi, G., Baruonu, F., Ayoglu, F., Cinar, F., Karadenizli, A., Ugur, M. B., et al. (2006). Tularemia, a reemerging disease in northwest Turkey: epidemiological investigation and evaluation of treatment responses. Jpn. J. Infect. Dis. 59, 229-234.
23. Chain, P. S., Carniel, E., Larimer, F. W., Lamerdin, J., Stoutland, P. O., Regala, W. M., et al. (2004). Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc. Natl. Acad. Sci. U.S.A. 101, 13826-13831. doi: 10.1073/pnas.0404012101
24. Champion, M. D., Zeng, Q., Nix, E. B., Nano, F. E., Keim, P., Kodira, C. D., et al. (2009). Comparative genomic characterization of Francisella tularensis strains belonging to low and high virulence subspecies. PLoS Pathog. 5:e1000459. doi: 10.1371/journal.ppat.1000459
25. Chaudhuri, R. R., Ren, C. P., Desmond, L., Vincent, G. A., Silman, N. J., Brehm, J. K., et al. (2007). Genome sequencing shows that European isolates of Francisella tularensis subspecies tularensis are almost identical to US laboratory strain Schu S4. PLoS ONE 2:e352. doi: 10.1371/journal.pone.0000352
26. Child, R., Wehrly, T. D., Rockx-Brouwer, D., Dorward, D. W., and Celli, J. (2010). Acid phosphatases do not contribute to the pathogenesis of type A Francisella tularensis. Infect. Immun. 78, 59-67. doi: 10.1128/IAI.00965-09
27. Chou, A. Y., Kennett, N. J., Nix, E. B., Schmerk, C. L., Nano, F. E., and Elkins, K. L. (2013). Generation of protection against Francisella novicida in mice depends on the pathogenicity protein PdpA, but not PdpC or PdpD. Microbes Infect. 15, 816-827. doi: 10.1016/j.micinf.2013.07.005
28. Clarridge, J. E. 3rd., Raich, T. J., Sjösted, A., Sandström, G., Darouiche, R. O., Shawar, R. M., et al. (1996). Characterization of two unusual clinically significant Francisella strains. J. Clin. Microbiol. 34, 1995-2000.
29. Clay, C. D., Soni, S., Gunn, J. S., and Schlesinger, L. S. (2008). Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen. J. Immunol. 181, 5568-5578.
30. Clemens, D. L., Lee, B. Y., and Horwitz, M. A. (2005). Francisella tularensis enters macrophages via a novel process involving pseudopod loops. Infect. Immun. 73, 5892-5902. doi: 10.1128/IAI.73.9.5892-5902.2005
31. Cong, Y., Yu, J. J., Guentzel, M. N., Berton, M. T., Seshu, J., Klose, K. E., et al. (2009). Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge. Vaccine 27, 5554-5561. doi: 10.1016/j.vaccine.2009.07.034
32. Cowley, S. C., and Elkins, K. L. (2011). Immunity to Francisella. Front. Microbiol. 2:26. doi: 10.3389/fmicb.2011.00026
33. Cremer, T. J., Butchar, J. P., and Tridandapani, S. (2011). Francisella subverts innate immune signaling: focus on PI3K/Akt. Front. Microbiol. 5:13. doi: 10.3389/fmicb.2011.00013
34. Cremer, T. J., Ravneberg, D. H., Clay, C. D., Piper-Hunter, M. G., Marsh, C. B., Elton, T. S., et al. (2009). MiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation and enhanced pro-inflammatory cytokine response. PLoS ONE 4:e8508. doi: 10.1371/journal.pone.0008508
35. Dai, S., Rajaram, M. V., Curry, H. M., Leander, R., and Schlesinger, L. S. (2013). Fine tuning inflammation at the front door: macrophage complement receptor 3-mediates phagocytosis and immune suppression for Francisella tularensis. PLoS Pathog. 9:e1003114. doi: 10.1371/journal.ppat.1003114
36. De Bruin, O. M., Duplantis, B. N., Ludu, J. S., Hare, R. F., Nix, E. B., Schmerk, C. L., et al. (2011). The biochemical properties of the Francisella pathogenicity island (FPI)-encoded proteins IglA, IglB, IglC, PdpB and DotU suggest roles in type VI secretion. Microbiology 157, 3483-3491. doi: 10.1099/mic.0.052308-0
37. De Carvalho, I. L. S. N., Soares, T., Ze-Ze, L., and Nuncio, M. S. (2011). Francisella-like endosymbiont in Dermacentor reticulatus collected in Portugal. Vector Borne Zoonotic Dis. 11, 185-188. doi: 10.1089/vbz.2010.0014
38. Dennis, D. T., Inglesby, T. V., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., et al. (2001). Tularemia as a biological weapon: medical and public health management. J. Am. Med. Assoc. 285, 2763-2773. doi: 10.1001/jama.285.21.2763
39. Dotson, R. J., Rabadi, S. M., Westcott, E. L., Bradley, S., Catlett, S. V., Banik, S., et al. (2013). Repression of inflammasome by Francisella tularensis during early stages of infection. J. Biol. Chem. 288, 23844-23857. doi: 10.1074/jbc.M113.490086
40. Federal Register. (2012). Possession, Use, and Transfer of Select Agents and Toxins. 61083-61115. Available online at: https://federalregister.gov/a/2012-24389
41. Fernandes-Alnemri, T., Yu, J. W., Juliana, C., Solorzano, L., Kang, S., Wu, J., et al. (2010). The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat. Immunol. 11, 385-393. doi: 10.1038/ni.1859
42. Francis, E. (1925). Tularemia. J. Am. Med. Assoc. 84, 1243-1250.
43. Francis, E., and Felton, L. (1953). The isolation from the rocky mountain wood tick (Dermacentor andersoni) of strains of Bact. tularense of low virulence for guinea pigs and domestic rabbits. Public Health Rep. 57:44.
44. Gallagher, L. A., McKevitt, M., Ramage, E. R., and Manoil, C. (2008). Genetic dissection of the Francisella novicida restriction barrier. J. Bacteriol. 190, 7830-7837. doi: 10.1128/JB.01188-08
45. Garcia Del Blanco, N., Gutierrez Martin, C. B., De La Puente Redondo, V. A., and Rodriguez Ferri, E. F. (2004). In vitro susceptibility of field isolates of Francisella tularensis subsp. holarctica recovered in Spain to several antimicrobial agents. Res. Vet. Sci. 76, 195-198. doi: 10.1016/j.rvsc.2003.12.002
46. Georgi, E., Schacht, E., Scholz, H. C., and Splettstoesser, W. D. (2012). Standardized broth microdilution antimicrobial susceptibility testing of Francisella tularensis subsp. holarctica strains from Europe and rare Francisella species. J. Antimicrob. Chemother. 67, 2429-2433. doi: 10.1093/jac/dks238
47. Goethert, H. K., and Telford, S. R. 3rd. (2005). A new Francisella (Beggiatiales: Francisellaceae) inquiline within Dermacentor variabilis say (Acari: Ixodidae). J. Med. Entomol. 42, 502-505. doi: 10.1603/0022-2585(2005)042%5B0502:ANFBFI%5D2.0.CO;2
48. Gray, C. G., Cowley, S. C., Cheung, K. K., and Nano, F. E. (2002). The identification of five genetic loci of Francisella novicida associated with intracellular growth. FEMS Microbiol. Lett. 215, 53-56. doi: 10.1016/S0378-1097(02)00911-4
49. Gunn, J. S., and Ernst, R. K. (2007). The structure and function of Francisella lipopolysaccharide. Ann. N.Y. Acad. Sci. 1105, 202-218. doi: 10.1196/annals.1409.006
50. Hall, J. D., Woolard, M. D., Gunn, B. M., Craven, R. R., Taft-Benz, S., Frelinger, J. A., et al. (2008). Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112. Infect. Immun. 76, 5843-5852. doi: 10.1128/IAI.01176-08
51. Hollis, D. G., Weaver, R. E., Steigerwalt, A. G., Wenger, J. D., Moss, C. W., and Brenner, D. J. (1989). Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease. J. Clin. Microbiol. 27, 1601-1608.
52. Hopla, C. E. (1974). The ecology of tularemia. Adv. Vet. Sci. Comp. Med. 18, 25-53.
53. Huber, B., Escudero, R., Busse, H. J., Seibold, E., Scholz, H. C., Anda, P., et al. (2010). Description of Francisella hispaniensis sp. nov., isolated from human blood, reclassification of Francisella novicida (Larson et al. 1955) Olsufiev et al. 1959 as Francisella tularensis subsp. novicida comb. nov. and emended description of the genus Francisella. Int. J. Syst. Evol. Microbiol. 60, 1887-1896. doi: 10.1099/ijs.0.015941-0
54. Ikäheimo, I., Syrjälä, H., Karhukorpi, J., Schildt, R., and Koskela, M. (2000). In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals. J. Antimicrob. Chemother. 46, 287-290. doi: 10.1093/jac/46.2.287
55. Ivanov, I. N., Mitkova, N., Reye, A. L., Hubschen, J. M., Vatcheva-Dobrevska, R. S., Dobreva, E. G., et al. (2011). Detection of new Francisella-like tick endosymbionts in Hyalomma spp. and Rhipicephalus spp. (Acari: Ixodidae) from Bulgaria. Appl. Environ. Microbiol. 77, 5562-5565. doi: 10.1128/AEM.02934-10
56. Jellison, W. (1974). Tularemia in North America. Missoula, MT: University of Montana Foundation.
57. Johansson, A., Berglund, L., Gothefors, L., Sjöstedt, A., and Tärnvik, A. (2000). Ciprofloxacin for treatment of tularemia in children. Pediatr. Infect. Dis. J. 19, 449-453. doi: 10.1097/00006454-200005000-00011
58. Johansson, A., Celli, J., Conlan, W., Elkins, K. L., Forsman, M., Keim, P. S., et al. (2010). Objections to the transfer of Francisella novicida to the subspecies rank of Francisella tularensis. Int. J. Syst. Evol. Microbiol. 60, 1717-1718; author reply 1718-1720. doi: 10.1099/ijs.0.022830-0
59. Johansson, A., Urich, S. K., Chu, M. C., Sjöstedt, A., and Tärnvik, A. (2002). In vitro susceptibility to quinolones of Francisella tularensis subspecies tularensis. Scand. J. Infect. Dis. 34, 327-330. doi: 10.1080/00365540110080773
60. Jones, C. L., Napier, B. A., Sampson, T. R., Llewellyn, A. C., Schroeder, M. R., and Weiss, D. S. (2012). Subversion of host recognition and defense systems by Francisella spp. Microbiol. Mol. Biol. Rev. 76, 383-404. doi: 10.1128/MMBR.05027-11
61. Katz, J., Zhang, P., Martin, M., Vogel, S. N., and Michalek, S. M. (2006). Toll-like receptor 2 is required for inflammatory responses to Francisella tularensis LVS. Infect. Immun. 74, 2809-2816. doi: 10.1128/IAI.74.5.2809-2816.2006
62. Kaya, A., Uysal, I. O., Guven, A. S., Engin, A., Gulturk, A., Icagasioglu, F. D., et al. (2011). Treatment failure of gentamicin in pediatric patients with oropharyngeal tularemia. Med. Sci. Monit. 17, CR376-CR380. doi: 10.12659/MSM.881848
63. KEGG. (2014). Kyoto Encyclopedia of Genes and Genomes [Online]. (Accessed January 15, 2014). Available online at: http://www.genome.jp/kegg/kegg2.html
64. Kieffer, T. L., Cowley, S., Nano, F. E., and Elkins, K. L. (2003). Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis. Microbes Infect. 5, 397-403. doi: 10.1016/S1286-4579(03)00052-2
65. Kim, H. S., Schell, M. A., Yu, Y., Ulrich, R. L., Sarria, S. H., Nierman, W. C., et al. (2005). Bacterial genome adaptation to niches: divergence of the potential virulence genes in three Burkholderia species of different survival strategies. BMC Genomics 6:174. doi: 10.1186/1471-2164-6-174
66. Kim, T. H., Sebastian, S., Pinkham, J. T., Ross, R. A., Blalock, L. T., and Kasper, D. L. (2010). Characterization of the O-antigen polymerase (Wzy) of Francisella tularensis. J. Biol. Chem. 285, 27839-27849. doi: 10.1074/jbc.M110.143859
67. Klimpel, G. R., Eaves-Pyles, T., Moen, S. T., Taormina, J., Peterson, J. W., Chopra, A. K., et al. (2008). Levofloxacin rescues mice from lethal intra-nasal infections with virulent Francisella tularensis and induces immunity and production of protective antibody. Vaccine 26, 6874-6882. doi: 10.1016/j.vaccine.2008.09.077
68. Kreizinger, Z., Hornok, S., Dan, A., Hresko, S., Makrai, L., Magyar, T., et al. (2013). Prevalence of Francisella tularensis and Francisella-like endosymbionts in the tick population of Hungary and the genetic variability of Francisella-like agents. Vector Borne Zoonotic Dis. 13, 160-163. doi: 10.1089/vbz.2012.1065
69. Kugeler, K. J., Gurfield, N., Creek, J. G., Mahoney, K. S., Versage, J. L., and Petersen, J. M. (2005). Discrimination between Francisella tularensis and Francisella-like endosymbionts when screening ticks by PCR. Appl. Environ. Microbiol. 71, 7594-7597. doi: 10.1128/AEM.71.11.7594-7597.2005
70. Kugeler, K. J., Mead, P. S., Janusz, A. M., Staples, J. E., Kubota, K. A., Chalcraft, L. G., et al. (2009). Molecular epidemiology of Francisella tularensis in the United States. Clin. Infect. Dis. 48, 863-870. doi: 10.1086/597261
71. Kuske, C. R., Barns, S. M., Grow, C. C., Merrill, L., and Dunbar, J. (2006). Environmental survey for four pathogenic bacteria and closely related species using phylogenetic and functional genes. J. Forensic Sci. 51, 548-558. doi: 10.1111/j.1556-4029.2006.00131.x
72. Lapage, S. P. (1992). International Code of Nomenclature of Bacteria. Washington, DC: ASM Press.
73. Larson, C. L., Wicht, W., and Jellison, W. L. (1955). A new organism resembling P. tularensis isolated from water. Public Health Rep. 70, 253-258.
74. Larsson, P., Elfsmark, D., Svensson, K., Wikström, P., Forsman, M., Brettin, T., et al. (2009). Molecular evolutionary consequences of niche restriction in Francisella tularensis, a facultative intracellular pathogen. PLoS Pathog. 5:e1000472. doi: 10.1371/journal.ppat.1000472
75. Larsson, P., Oyston, P. C., Chain, P., Chu, M. C., Duffield, M., Fuxelius, H. H., et al. (2005). The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nat. Genet. 37, 153-159. doi: 10.1038/ng1499
76. Lauriano, C. M., Barker, J. R., Yoon, S. S., Nano, F. E., Arulanandam, B. P., Hassett, D. J., et al. (2004). MglA regulates transcription of virulence factors necessary for Francisella tularensis intraamoebae and intramacrophage survival. Proc. Natl. Acad. Sci. U.S.A. 101, 4246-4249. doi: 10.1073/pnas.0307690101
77. Leelaporn, A., Yongyod, S., Limsrivanichakorn, S., Yungyuen, T., and Kiratisin, P. (2008). Francisella novicida bacteremia, Thailand. Emerging Infect. Dis. 14, 1935-1937. doi: 10.3201/eid1412.080435
78. Lim, K. H., and Staudt, L. M. (2013). Toll-like receptor signaling. Cold Spring Harb. Perspect. Biol. 5:a011247. doi: 10.1101/cshperspect.a011247
79. Machado-Ferreira, E., Piesman, J., Zeidner, N. S., and Soares, C. A. (2009). Francisella-like endosymbiont DNA and Francisella tularensis virulence-related genes in Brazilian ticks (Acari: Ixodidae). J. Med. Entomol. 46, 369-374. doi: 10.1603/033.046.0224
80. Maier, T. M., Casey, M. S., Becker, R. H., Dorsey, C. W., Glass, E. M., Maltsev, N., et al. (2007). Identification of Francisella tularensis Himar1-based transposon mutants defective for replication in macrophages. Infect. Immun. 75, 5376-5389. doi: 10.1128/IAI.00238-07
81. Maier, T. M., Havig, A., Casey, M., Nano, F. E., Frank, D. W., and Zahrt, T. C. (2004). Construction and characterization of a highly efficient Francisella shuttle plasmid. Appl. Environ. Microbiol. 70, 7511-7519. doi: 10.1128/AEM.70.12.7511-7519.2004
82. Malik, M., Bakshi, C. S., Sahay, B., Shah, A., Lotz, S. A., and Sellati, T. J. (2006). Toll-like receptor 2 is required for control of pulmonary infection with Francisella tularensis. Infect. Immun. 74, 3657-3662. doi: 10.1128/IAI.02030-05
83. Mares, C. A., Ojeda, S. S., Morris, E. G., Li, Q., and Teale, J. M. (2008). Initial delay in the immune response to Francisella tularensis is followed by hypercytokinemia characteristic of severe sepsis and correlating with upregulation and release of damage-associated molecular patterns. Infect. Immun. 76, 3001-3010. doi: 10.1128/IAI.00215-08
84. Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'rourke, K., Roose-Girma, M., et al. (2006). Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228-232. doi: 10.1038/nature04515
85. McCoy, G. W., and Chapin, C. C. (1912). Studies of plague, a plague-like disease and tuberculosis among rodents in California. J. Infect. Dis. VI, 170-180.
86. McCrumb, F. R. (1961). Aerosol infection of man with Pasteurella tularensis. Bacteriol. Rev. 25, 262-267.
87. Mdluli, K. E., Anthony, L. S., Baron, G. S., McDonald, M. K., Myltseva, S. V., and Nano, F. E. (1994). Serum-sensitive mutation of Francisella novicida: association with an ABC transporter gene. Microbiology 140(Pt 12), 3309-3318.
88. Medina, E. A., Morris, I. R., and Berton, M. T. (2010). Phosphatidylinositol 3-kinase activation attenuates the TLR2-mediated macrophage proinflammatory cytokine response to Francisella tularensis live vaccine strain. J. Immunol. 185, 7562-7572. doi: 10.4049/jimmunol.0903790
89. Meibom, K. L., and Charbit, A. (2010). Francisella tularensis metabolism and its relation to virulence. Front. Microbiol. 1:140. doi: 10.3389/fmicb.2010.00140
90. Meric, M., Willke, A., Finke, E. J., Grunow, R., Sayan, M., Erdogan, S., et al. (2008). Evaluation of clinical, laboratory, and therapeutic features of 145 tularemia cases: the role of quinolones in oropharyngeal tularemia. APMIS 116, 66-73. doi: 10.1111/j.1600-0463.2008.00901.x
91. Meshcheriakova, I. S., Kormilitsyna, M. I., Rodionova, I. V., and Konstantinova, N. D. (1995). [The characteristics of new species of pathogenic microorganisms in the genus Francisella]. Zh. Mikrobiol. Epidemiol. Immunobiol. 5, 3-8.
92. Modise, T., Ryder, C., Mane, S. P., Bandara, A. B., Jensen, R. V., and Inzana, T. J. (2012). Genomic comparison between a virulent type A1 strain of Francisella tularensis and its attenuated O-antigen mutant. J. Bacteriol. 194, 2775-2776. doi: 10.1128/JB.00152-12
93. Molins, C. R., Delorey, M. J., Yockey, B. M., Young, J. W., Sheldon, S. W., Reese, S. M., et al. (2010). Virulence differences among Francisella tularensis subsp. tularensis clades in mice. PLoS ONE 5:e10205. doi: 10.1371/journal.pone.0010205
94. Moran, N. A. (2002). Microbial minimalism: genome reduction in bacterial pathogens. Cell 108, 583-586. doi: 10.1016/S0092-8674(02)00665-7
95. Mortensen, B. L., Fuller, J. R., Taft-Benz, S., Kijek, T. M., Miller, C. N., Huang, M. T., et al. (2010). Effects of the putative transcriptional regulator IclR on Francisella tularensis pathogenesis. Infect. Immun. 78, 5022-5032. doi: 10.1128/IAI.00544-10
96. Nano, F. E., and Schmerk, C. (2007). The Francisella pathogenicity island. Ann. N.Y. Acad. Sci. 1105, 122-137. doi: 10.1196/annals.1409.000
97. Nano, F. E., Zhang, N., Cowley, S. C., Klose, K. E., Cheung, K. K., Roberts, M. J., et al. (2004). A Francisella tularensis pathogenicity island required for intramacrophage growth. J. Bacteriol. 186, 6430-6436. doi: 10.1128/JB.186.19.6430-6436.2004
98. Nelson, M., Lever, M. S., Dean, R. E., Pearce, P. C., Stevens, D. J., and Simpson, A. J. (2010). Bioavailability and efficacy of levofloxacin against Francisella tularensis in the common marmoset (Callithrix jacchus). Antimicrob. Agents Chemother. 54, 3922-3926. doi: 10.1128/AAC.00390-10
99. Okan, N. A., Chalabaev, S., Kim, T. H., Fink, A., Ross, R. A., and Kasper, D. L. (2013). Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity. MBio 4, e00638-e00612. doi: 10.1128/mBio.00638-12
100. Okan, N. A., and Kasper, D. L. (2013). The atypical lipopolysaccharide of Francisella. Carbohydr. Res. 378, 79-83. doi: 10.1016/j.carres.2013.06.015
101. Olsufiev, N. G., Emelyanova, O. S., and Dunayeva, T. N. (1959). Comparative study of strains of B. tularense in the old and new world and their taxonomy. J. Hyg. Epidemiol. Microbiol. Immunol. 3, 138-149.
102. Ong, C., Ooi, C. H., Wang, D., Chong, H., Ng, K. C., Rodrigues, F., et al. (2004). Patterns of large-scale genomic variation in virulent and avirulent Burkholderia species. Genome Res. 14, 2295-2307. doi: 10.1101/gr.1608904
103. Owen, C. R., Buker, E. O., Jellison, W. L., Lackman, D. B., and Bell, J. F. (1964). Comparative studies of Francisella tularensis and Francisella novicida. J. Bacteriol. 87, 676-683.
104. Pammit, M. A., Budhavarapu, V. N., Raulie, E. K., Klose, K. E., Teale, J. M., and Arulanandam, B. P. (2004). Intranasal interleukin-12 treatment promotes antimicrobial clearance and survival in pulmonary Francisella tularensis subsp. novicida infection. Antimicrob. Agents Chemother. 48, 4513-4519. doi: 10.1128/AAC.48.12.4513-4519.2004
105. Pechous, R. D., McCarthy, T. R., Mohapatra, N. P., Soni, S., Penoske, R. M., Salzman, N. H., et al. (2008). A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge. PLoS ONE 3:e2487. doi: 10.1371/journal.pone.0002487
106. Petersen, J. M., Carlson, J., Yockey, B., Pillai, S., Kuske, C., Garbalena, G., et al. (2009a). Direct isolation of Francisella spp. from environmental samples. Lett. Appl. Microbiol. 48, 663-667. doi: 10.1111/j.1472-765X.2009.02589.x
107. Petersen, J. M., Mead, P. S., and Schriefer, M. E. (2009b). Francisella tularensis: an arthropod-borne pathogen. Vet. Res. 40, 7. doi: 10.1051/vetres:2008045
108. Petersen, J. M., and Molins, C. R. (2010). Subpopulations of Francisella tularensis ssp. tularensis and holarctica: identification and associated epidemiology. Future Microbiol. 5, 649-661. doi: 10.2217/fmb.10.17
109. Qin, A., Scott, D. W., and Mann, B. J. (2008). Francisella tularensis subsp. tularensis Schu S4 disulfide bond formation protein B, but not an RND-type efflux pump, is required for virulence. Infect. Immun. 76, 3086-3092. doi: 10.1128/IAI.00363-08
110. Ray, H. J., Chu, P., Wu, T. H., Lyons, C. R., Murthy, A. K., Guentzel, M. N., et al. (2010). The Fischer 344 rat reflects human susceptibility to francisella pulmonary challenge and provides a new platform for virulence and protection studies. PLoS ONE 5:e9952. doi: 10.1371/journal.pone.0009952
111. Respicio-Kingry, L. B., Yockey, M., Yendell, B., Ratard, S., Hand, R., Balsamo, J., et al. (2012). "Laboratory analysis of a Francisella novicida outbreak among prisoners at a Louisiana correctional facility, 2011," in 7th International Conference on Tularemia (Breckenridge, CO).
112. Richard, K., Mann, B. J., Stocker, L., Barry, E. M., Qin, A., Cole, L. E., et al. (2014). Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain. Clin. Vaccine Immunol. 21, 212-226. doi: 10.1128/CVI.00738-13
113. Rohmer, L., Fong, C., Abmayr, S., Wasnick, M., Larson Freeman, T. J., Radey, M., et al. (2007). Comparison of Francisella tularensis genomes reveals evolutionary events associated with the emergence of human pathogenic strains. Genome Biol. 8:R102. doi: 10.1186/gb-2007-8-6-r102
114. Sampson, T. R., Saroj, S. D., Llewellyn, A. C., Tzeng, Y. L., and Weiss, D. S. (2013). A CRISPR/Cas system mediates bacterial innate immune evasion and virulence. Nature 497, 254-257. doi: 10.1038/nature12048
115. Sampson, T. R., and Weiss, D. S. (2013a). Alternative roles for CRISPR/Cas systems in bacterial pathogenesis. PLoS Pathog. 9:e1003621. doi: 10.1371/journal.ppat.1003621
116. Sampson, T. R., and Weiss, D. S. (2013b). Degeneration of a CRISPR/Cas system and its regulatory target during the evolution of a pathogen. RNA Biol. 10, 1618-1622. doi: 10.4161/rna.26423
117. Schmerk, C. L., Duplantis, B. N., Howard, P. L., and Nano, F. E. (2009). A Francisella novicida pdpA mutant exhibits limited intracellular replication and remains associated with the lysosomal marker LAMP-1. Microbiology 155, 1498-1504. doi: 10.1099/mic.0.025445-0
118. Schunder, E., Rydzewski, K., Grunow, R., and Heuner, K. (2013). First indication for a functional CRISPR/Cas system in Francisella tularensis. Int. J. Med. Microbiol. 303, 51-60. doi: 10.1016/j.ijmm.2012.11.004
119. Scoles, G. A. (2004). Phylogenetic analysis of the Francisella-like endosymbionts of Dermacentor ticks. J. Med. Entomol. 41, 277-286. doi: 10.1603/0022-2585-41.3.277
120. Sharma, J., Li, Q., Mishra, B. B., Pena, C., and Teale, J. M. (2009). Lethal pulmonary infection with Francisella novicida is associated with severe sepsis. J. Leukoc. Biol. 86, 491-504. doi: 10.1189/jlb.1208728
121. Sjödin, A., Svensson, K., Ohrman, C., Ahlinder, J., Lindgren, P., Duodu, S., et al. (2012). Genome characterisation of the genus Francisella reveals insight into similar evolutionary paths in pathogens of mammals and fish. BMC Genomics 13:268. doi: 10.1186/1471-2164-13-268
122. Skerman, V. B. D., McGowan, V., and Sneath, P. H. A., (eds.). (1980). Approved lists of bacterial names. Int. J. Syst. Bacteriol. 30, 225-420.
123. Stackebrandt, E., Frederiksen, W., Garrity, G. M., Grimont, P. A., Kampfer, P., Maiden, M. C., et al. (2002). Report of the ad hoc committee for the re-evaluation of the species definition in bacteriology. Int. J. Syst. Evol. Microbiol. 52, 1043-1047. doi: 10.1099/ijs.0.02360-0
124. Steward, J., Piercy, T., Lever, M. S., Simpson, A. J., and Brooks, T. J. (2006). Treatment of murine pneumonic Francisella tularensis infection with gatifloxacin, moxifloxacin or ciprofloxacin. Int. J. Antimicrob. Agents 27, 439-443. doi: 10.1016/j.ijantimicag.2006.02.006
125. Sutera, V., Levert, M., Burmeister, W. P., Schneider, D., and Maurin, M. (2014). Evolution toward high-level fluoroquinolone resistance in Francisella species. J. Antimicrob. Chemother. 69, 101-110. doi: 10.1093/jac/dkt321
126. Svensson, K., Sjödin, A., Bystrom, M., Granberg, M., Brittnacher, M. J., Rohmer, L., et al. (2012). Genome sequence of Francisella tularensis subspecies holarctica strain FSC200, isolated from a child with tularemia. J. Bacteriol. 194, 6965-6966. doi: 10.1128/JB.01040-12
127. Tärnvik, A., and Berglund, L. (2003). Tularaemia. Eur. Respir. J. 21, 361-373. doi: 10.1183/09031936.03.00088903
128. Telepnev, M., Golovliov, I., Grundström, T., Tärnvik, A., and Sjöstedt, A. (2003). Francisella tularensis inhibits Toll-like receptor-mediated activation of intracellular signalling and secretion of TNF-alpha and IL-1 from murine macrophages. Cell. Microbiol. 5, 41-51. doi: 10.1046/j.1462-5822.2003.00251.x
129. Tempel, R., Lai, X. H., Crosa, L., Kozlowicz, B., and Heffron, F. (2006). Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge. Infect. Immun. 74, 5095-5105. doi: 10.1128/IAI.00598-06
130. Thomas, R. M., Titball, R. W., Oyston, P. C., Griffin, K., Waters, E., Hitchen, P. G., et al. (2007). The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens. Infect. Immun. 75, 371-378. doi: 10.1128/IAI.01241-06
131. Thomas, R. M., Twine, S. M., Fulton, K. M., Tessier, L., Kilmury, S. L., Ding, W., et al. (2011). Glycosylation of DsbA in Francisella tularensis subsp. tularensis. J. Bacteriol. 193, 5498-5509. doi: 10.1128/JB.00438-11
132. Tindall, B. J., Kampfer, P., Euzeby, J. P., and Oren, A. (2006). Valid publication of names of prokaryotes according to the rules of nomenclature: past history and current practice. Int. J. Syst. Evol. Microbiol. 56, 2715-2720. doi: 10.1099/ijs.0.64780-0
133. Tomaso, H., Al Dahouk, S., Hofer, E., Splettstoesser, W. D., Treu, T. M., Dierich, M. P., et al. (2005). Antimicrobial susceptibilities of Austrian Francisella tularensis holarctica biovar II strains. Int. J. Antimicrob. Agents 26, 279-284. doi: 10.1016/j.ijantimicag.2005.07.003
134. Urich, S. K., and Petersen, J. M. (2008). In vitro susceptibility of isolates of Francisella tularensis types A and B from North America. Antimicrob. Agents Chemother. 52, 2276-2278. doi: 10.1128/AAC.01584-07
135. Valade, E., Vaissaire, J., Merens, A., Hernandez, E., Gros, C., Le Doujet, C., et al. (2008). Susceptibility of 71 French isolates of Francisella tularensis subsp. holarctica to eight antibiotics and accuracy of the Etest method. J. Antimicrob. Chemother. 62, 208-210. doi: 10.1093/jac/dkn146
136. Vinogradov, E., Conlan, W. J., Gunn, J. S., and Perry, M. B. (2004). Characterization of the lipopolysaccharide O-antigen of Francisella novicida (U112). Carbohydr. Res. 339, 649-654. doi: 10.1016/j.carres.2003.12.013
137. Vinogradov, E., and Perry, M. B. (2004). Characterisation of the core part of the lipopolysaccharide O-antigen of Francisella novicida (U112). Carbohydr. Res. 339, 1643-1648. doi: 10.1016/j.carres.2004.04.013
138. Vinogradov, E., Perry, M. B., and Conlan, J. W. (2002). Structural analysis of Francisella tularensis lipopolysaccharide. Eur. J. Biochem. 269, 6112-6118. doi: 10.1046/j.1432-1033.2002.03321.x
139. Weber, I. B., Turabelidze, G., Patrick, S., Griffith, K. S., Kugeler, K. J., and Mead, P. S. (2012). Clinical recognition and management of tularemia in Missouri: a retrospective records review of 121 cases. Clin. Infect. Dis. 55, 1283-1290. doi: 10.1093/cid/cis706
140. Weiss, D. S., Brotcke, A., Henry, T., Margolis, J. J., Chan, K., and Monack, D. M. (2007a). In vivo negative selection screen identifies genes required for Francisella virulence. Proc. Natl. Acad. Sci. U.S.A. 104, 6037-6042. doi: 10.1073/pnas.0609675104
141. Weiss, D. S., Henry, T., and Monack, D. M. (2007b). Francisella tularensis: activation of the inflammasome. Ann. N.Y. Acad. Sci. 1105, 219-237. doi: 10.1196/annals.1409.005
142. Whipp, M. J., Davis, J. M., Lum, G., De Boer, J., Zhou, Y., Bearden, S. W., et al. (2003). Characterization of a novicida-like subspecies of Francisella tularensis isolated in Australia. J. Med. Microbiol. 52, 839-842. doi: 10.1099/jmm.0.05245-0
143. Whitehouse, C. A., Kesterson, K. E., Duncan, D. D., Eshoo, M. W., and Wolcott, M. (2012). Identification and characterization of Francisella species from natural warm springs in Utah, USA. Lett. Appl. Microbiol. 54, 313-324. doi: 10.1111/j.1472-765X.2012.03214.x
144. WHO. (2007). WHO Guidelines on Tularaemia. Geneva: World Health Organization.
145. Zarrella, T. M., Singh, A., Bitsaktsis, C., Rahman, T., Sahay, B., Feustel, P. J., et al. (2011). Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity. PLoS ONE 6:e22335. doi: 10.1371/journal.pone.0022335
146. Zimmer, A. L., Thoden, J. B., and Holden, H. M. (2013). Three-dimensional structure of a sugar N-formyltransferase from Francisella tularensis. Protein Sci. doi: 10.1002/pro.2409. [Epub ahead of print].
147. Zogaj, X., Wyatt, G. C., and Klose, K. E. (2012). Cyclic di-GMP stimulates biofilm formation and inhibits virulence of Francisella novicida. Infect. Immun. 80, 4239-4247. doi: 10.1128/IAI.00702-12